ArticleBreast cancer : basic and clinical research2019

Pertuzumab and Trastuzumab Emtansine for Human Epidermal Growth Factor Receptor-2-Positive Metastatic Breast Cancer: Contemporary Population-Based Outcomes.

Sasha Lupichuk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.